Novogene: 2025 Net Profit of 166 Million Yuan, Down 15.59% Year-over-Year

Nuohe Zhiyuan Announces Earnings Brief, Achieving a Total Revenue of 2.21 Billion Yuan in 2025, Up 4.66% Year-over-Year; Net Profit of 166 Million Yuan, Down 15.59% Year-over-Year. During the reporting period, despite macroeconomic fluctuations and short-term funding variations from some clients, the company actively responded, and revenue still achieved steady growth. To seize long-term market opportunities, the company continues to strengthen its core competitiveness: significantly increasing R&D investment, focusing on AI-enabled scientific research, single-cell and spatial multi-omics, protein and metabolomics solutions, and clinical translation to enhance product leadership.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments